Publications by authors named "Alessandro Gritti"
Article Synopsis
- The study evaluated the safety and effectiveness of the dermal filler VYC-17.5 L for treating marionette lines in adults over a 12-month period.
- Nearly 70% of participants showed improvement in marionette lines, with significant enhancements noted in overall facial appearance and satisfaction scores.
- Most side effects were mild and resolved quickly, indicating that VYC-17.5 L is an effective and well-tolerated treatment option for this aging feature.
Article Synopsis
- HArmonyCa™ is a new hybrid dermal filler combining hyaluronic acid and calcium hydroxylapatite, aimed at improving facial aging and skin conditions.* -
- The study involved 129 patients who underwent HArmonyCa™ treatment, with outcomes evaluated nine months post-treatment using both physician and patient satisfaction assessments.* -
- Results indicated significant improvements in facial appearance and movement, with only minor adverse effects reported, demonstrating the treatment's safety and compatibility with other cosmetic interventions.*
Article Synopsis
- * Fifty-four patients received treatment, and the results showed significant size reductions in various types of malformations, particularly lymphatic malformations and salivary epithelial duct cysts, with fewer interventions needed for macrocystic lymphatic types.
- * Overall, percutaneous sclerosant injection is suggested as a first-line treatment, especially for lymphatic malformations and salivary duct cysts, while the results for mucoceles and branchial cysts were less favorable.
Background: A validated scale is needed for objective and reproducible comparisons of marionette lines before and after treatment in clinical studies.
Objective: To describe the development and validation of a 5-point photonumeric marionette lines scale.
Methods: The scale was developed to include an assessment guide, verbal descriptors, and real and morphed subject images for each scale grade.
Infantile hemangiomas (IH) complicated by ulceration, disfigurement, functional impairment or life-threatening conditions need early, safe and effective treatment. This study explores the impact of propranolol on complicated IH. We report our experience of 62 patients treated with oral propranolol for complicated IH.
View Article and Find Full Text PDF